You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ACAD Sale Disclosure
Kihara James · SEC Form 4 · Filed Jun 29, 2026
Sale
Calculated transaction value
$297.91K
Kihara James Principal Accounting Officer
ACAD
Transaction date
Jun 26, 2026
Public filing date
Jun 29, 2026
Filing lag
Filed 3 days later
ACAD daily price context
Close on/before transaction
$25.32
Jun 26, 2026
First close after public filing
$25.3
Jun 30, 2026
30-day return after filing
+4.11%
Through Jul 29, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,421 shares @ $26.08
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001816160-26-000009
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$297.91K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Acadia Pharmaceuticals Inc ACAD Current | Sale | Jun 26, 2026 | $297.91K |